Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience, Cancer Chemotherapy and Pharmacology, March 2015, Springer Science + Business Media,
DOI: 10.1007/s00280-015-2715-x.
You can read the full text:
Contributors
The following have contributed to this page
